Loading: 100%
OWENS & MINOR INC/VA/ logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 5,600 (as per Q3 2016)no data available
Sector Medical Distribution, HealthcareMedical Distribution, Healthcareno data available
Ticker OMIno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 172427303336
datesClosing price (adj.)
13.10.201727.98
11.10.201728.09
04.10.201729.23
27.09.201729.76
20.09.201728.84
13.09.201728.23
06.09.201728.23
30.08.201727.49
23.08.201726.85
16.08.201727.88
09.08.201728.28
02.08.201730.05
26.07.201731.92
19.07.201731.70
12.07.201731.44
05.07.201731.63
27.06.201731.96
20.06.201731.21
13.06.201731.80
06.06.201731.23
30.05.201731.30
23.05.201731.70
16.05.201731.78
09.05.201731.45
02.05.201734.15
25.04.201733.61
18.04.201732.74
11.04.201734.09
04.04.201733.51
28.03.201733.80
21.03.201734.10
14.03.201734.96
07.03.201734.69
28.02.201735.22
21.02.201735.10
14.02.201735.21
07.02.201734.80
31.01.201735.03
24.01.201735.56
17.01.201735.84
10.01.201735.57
03.01.201735.44
27.12.201634.92
19.12.201634.19
12.12.201634.17
05.12.201633.12
28.11.201633.13
21.11.201632.56
14.11.201631.75
07.11.201630.96
31.10.201631.45
24.10.201632.14
17.10.201631.84
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
27.98n/a
Market Capitalisation
in million USD
1,721n/a
Enterprise Value
in million USD
2,074n/a
Common Shares Outstanding
as per Oct 28, 2016
61,509,219n/a
Preferred Shares Outstanding
as per Oct 28, 2016
n/a
Average Basic Shares Outstanding
TTM
61,547,750n/a
Average Diluted Shares Outstanding
TTM
61,548,250n/a
Index Membership
n/a
Business Summary
Owens & Minor Inc is a healthcare logistics firm distributing low-tech, consumable medical supplies to acute-care hospitals. The company distributes products to healthcare service providers under various brands such as MediChoice and ArcRoyal.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 9,843n/a
Gross Profit 1,205n/a
Operating Income 235n/a
EBITDA 291n/a
Net Profit 114n/a
Balance Sheet
Cash and Cash Equivalents 213n/a
Receivables 0n/a
Total Current Assets 2,021n/a
PP&E 199n/a
Total Assets 2,795n/a
Accounts Payable 769n/a
Current Debt 0n/a
Total Current Liabilities 1,094n/a
Long-Term Debt 566n/a
Total Liabilities 1,808n/a
Total Equity 987n/a
Cash Flow
Depreciation & Amortisation 56n/a
Change in Working Capital 36n/a
Operating Cash Flow 207n/a
Net Change in PP&E and Intangibles -21n/a
Investing Cash Flow -21n/a
Dividends Paid -64n/a
Financing Cash Flow -103n/a
Total Change in Cash 88n/a
Free Cash Flow 240n/a
Profitability Ratios
Gross Margin 12.2%n/a
Operating Margin 2.4%n/a
Net Profit Margin 1.2%n/a
Return on Equity 11.5%n/a
Return on Assets 4.1%n/a
Per Share Figures
Basic EPS 1.85n/a
Diluted EPS 1.85n/a
Sales per Share 159.92n/a
Book Value per Share 16.03n/a
FCF per Share 3.89n/a
Dividends per Share 1.03n/a
Price Multiples
Price to Earnings Ratio 15.14n/a
Price to Sales Ratio 0.18n/a
Price to Book Value 1.75n/a
Price to Free Cash Flow 7.19n/a
Valuation Metrics
EV/EBITDA 7.12n/a
EV/Sales 0.21n/a
Book to Market Value 0.57n/a
Other Ratios
Current Ratio 184.7%n/a
Liabilities to Equity Ratio 183.2%n/a
Debt to Assets Ratio 20.3%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
7,243
8,038
8,124
8,628
8,868
9,072
9,440
9,773
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-6,502
-7,223
-7,316
-7,770
-7,944
-7,954
-8,270
-8,558
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
741
814
808
858
925
1,117
1,170
1,215
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-560
-613
-612
-641
-718
-907
-968
-986
Selling, General & Administrative
-545
-592
-564
-611
-683
-864
-927
-934
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
0
Depreciation & Amortization
-22
-25
-29
-34
-40
-51
-57
-60
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
6
4
-18
4
4
8
16
8
Operating Income (Loss)
181
201
196
217
207
211
202
229
Non-Operating Income (Loss)
-16
-13
-14
-14
-13
-13
-18
-27
Interest Expense, net
-16
-13
-14
-14
-13
-13
-18
-27
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
165
188
182
203
194
197
184
202
Abnormal Gains (Losses)
0
0
0
-13
-10
-12
-58
-28
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
165
188
182
190
183
185
126
173
Income Tax (Expense) Benefit, net
-63
-71
-71
-75
-74
-74
-60
-70
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
101
117
111
115
109
111
67
103
Net Extraordinary Gains (Losses)
-8
-12
0
0
0
0
0
0
Discontinued Operations
-8
-12
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
93
105
111
115
109
111
67
103
Minority Interest
0
0
0
0
0
0
0
0
Net Income
93
105
111
115
109
111
67
103
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
93
105
111
115
109
111
67
103
Remarks
restated on Feb 25, 2011 n/a
calculated values,
restated on Feb 24, 2012 n/a
calculated values,
restated on Feb 22, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 23, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
96
159
136
98
102
57
161
Cash & Cash Equivalents
n/a
96
159
136
98
102
57
161
Short Term Investments
n/a
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
498
472
507
537
573
626
588
Accounts Receivable, Net
n/a
0
0
0
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
690
720
806
764
772
872
941
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
58
53
77
231
280
314
285
Prepaid Expenses
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
58
53
77
231
280
314
285
Total Current Assets
n/a
1,342
1,404
1,526
1,630
1,726
1,870
1,975
Property, Plant & Equipment, Net
n/a
85
102
108
192
192
233
209
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
320
317
313
392
406
633
590
Intangible Assets
n/a
28
25
22
42
40
109
95
Goodwill
n/a
247
247
248
275
275
423
420
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
45
45
42
75
90
101
75
Total Noncurrent Assets
n/a
405
418
421
584
598
866
799
Total Assets
n/a
1,747
1,822
1,947
2,214
2,324
2,735
2,774
Liabilities and owners' equity
Payables & Accruals
n/a
582 581874000
552 552323000
596 596461000
629 628605000
667 667168000
640 640353000
757 756516000
Accounts Payable
n/a
547 546989000
532 531735000
576 575793000
603 603137000
644 643872000
609 608846000
711 710609000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
35 34885000
21 20588000
21 20668000
25 25468000
23 23296000
32 31507000
46 45907000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
118 118242000
142 142158000
136 135904000
297 297031000
323 323040000
326 326223000
307 307073000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
26 25784000
39 39082000
42 42296000
42 42107000
42 41613000
0 0
0 0
Discontinued Operations
n/a
2 1939000
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
91 90519000
103 103076000
94 93608000
255 254924000
281 281427000
326 326223000
307 307073000
Total Current Liabilities
n/a
700 700116000
694 694481000
732 732365000
926 925636000
990 990208000
967 966576000
1,064 1063589000
Long Term Debt
n/a
208 208418000
209 209096000
213 212681000
215 215383000
213 212786000
609 608551000
568 568495000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
69 69375000
61 60944000
83 82552000
100 99723000
96 96005000
169 169441000
149 149102000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
9 8947000
12 12107000
22 21894000
36 36269000
44 43727000
102 101880000
86 86326000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
60 60428000
49 48837000
61 60658000
63 63454000
52 52278000
68 67561000
63 62776000
Total Noncurrent Liabilities
n/a
278 277793000
270 270040000
295 295233000
315 315106000
309 308791000
778 777992000
718 717597000
Total Liabilities
n/a
978 977909000
965 964521000
1,028 1027598000
1,241 1240742000
1,299 1298999000
1,745 1744568000
1,781 1781186000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
278 277732000
292 292314000
306 305952000
314 313938000
323 322798000
329 329074000
338 337549000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
504 504480000
570 570320000
620 619629000
659 658994000
692 691547000
686 685765000
707 706866000
Other Equity
n/a
-13 -13033000
-5 -5116000
-7 -7494000
0 -406000
10 9568000
-24 -24001000
-52 -51825000
Equity Before Minority Interest
n/a
769 769179000
858 857518000
918 918087000
973 972526000
1,024 1023913000
991 990838000
993 992590000
Minority Interest
n/a
0 0
0 0
1 1130000
1 1130000
1 1130000
0 0
0 0
Total Equity
n/a
769 769179000
858 857518000
919 919217000
974 973656000
1,025 1025043000
991 990838000
993 992590000
Total Liabilities & Equity
n/a
1,747 1747088000
1,822 1822039000
1,947 1946815000
2,214 2214398000
2,324 2324042000
2,735 2735406000
2,774 2773776000
Remarks restated on n/a restated on Feb 25, 2011 n/a restated on Feb 24, 2012 n/a restated on Feb 22, 2013 n/a restated on Feb 25, 2014 n/a restated on Feb 23, 2015 n/a restated on Feb 25, 2016 n/a restated on Nov 2, 2016 n/a
Cash Flow StatementCF data quality: 55% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
101
117
111
115
109
111
67
103
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
22
25
29
34
40
51
63
66
Non-Cash Items
44
22
26
23
7
10
19
7
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
-104
53
-23
-104
63
-31
-153
93
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
63
218
143
68
219
141
-4
270
Change in Fixed Assets & Intangibles
-27
-28
-37
-34
23
-57
-71
-36
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
-155
0
-249
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
-97
7
0
0
0
0
2
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-123
-21
-37
-34
-133
-57
-317
-36
Dividends Paid
-33
-38
-45
-51
-56
-61
-63
-64
Cash From (Repayment of) Debt
74
-151
0
0
0
0
364
-34
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
9
7
7
-7
-10
-14
-9
-20
Increase in Capital Stock
9
7
7
9
5
5
1
0
Decrease in Capital Stock
0
0
0
-16
-15
-19
-10
-20
Other Financing Activities
15
1
-3
0
-3
-8
-14
-7
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
65
-182
-41
-58
-68
-82
279
-124
Net Cash Before Disc. Operations and FX
5
15
65
-23
17
1
-42
109
Change in Cash from Disc. Operations and Other
-14
84
-3
-1
0
0
0
0
Net Cash Before FX
-10
99
61
-24
17
1
-42
109
Effect of Foreign Exchange Rates
0
0
0
0
3
3
-3
-5
Net Changes in Cash
-10
99
61
-24
20
4
-45
104
Remarks
restated on Feb 25, 2011 n/a
calculated values,
restated on Feb 24, 2012 n/a
calculated values,
restated on Feb 22, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 23, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo